188 related articles for article (PubMed ID: 33099481)
1. Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.
Yoon N; Kim HS; Lee JW; Lee EJ; Maeng LS; Yoon WS
Cancer Genomics Proteomics; 2020; 17(6):803-812. PubMed ID: 33099481
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
[No Abstract] [Full Text] [Related]
4. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary Trajectories of IDH
Körber V; Yang J; Barah P; Wu Y; Stichel D; Gu Z; Fletcher MNC; Jones D; Hentschel B; Lamszus K; Tonn JC; Schackert G; Sabel M; Felsberg J; Zacher A; Kaulich K; Hübschmann D; Herold-Mende C; von Deimling A; Weller M; Radlwimmer B; Schlesner M; Reifenberger G; Höfer T; Lichter P
Cancer Cell; 2019 Apr; 35(4):692-704.e12. PubMed ID: 30905762
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma.
Hoffman M; Gillmor AH; Kunz DJ; Johnston MJ; Nikolic A; Narta K; Zarrei M; King J; Ellestad K; Dang NH; Cavalli FMG; Kushida MM; Coutinho FJ; Zhu Y; Luu B; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Pugh TJ; Dirks PB; Strother D; Lafay-Cousin L; Resnick AC; Scherer S; Senger DL; Simons BD; Chan JA; Morrissy AS; Gallo M
Cancer Res; 2019 May; 79(9):2111-2123. PubMed ID: 30877103
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
[TBL] [Abstract][Full Text] [Related]
8. Clonal evolution of glioblastoma under therapy.
Wang J; Cazzato E; Ladewig E; Frattini V; Rosenbloom DI; Zairis S; Abate F; Liu Z; Elliott O; Shin YJ; Lee JK; Lee IH; Park WY; Eoli M; Blumberg AJ; Lasorella A; Nam DH; Finocchiaro G; Iavarone A; Rabadan R
Nat Genet; 2016 Jul; 48(7):768-76. PubMed ID: 27270107
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
[TBL] [Abstract][Full Text] [Related]
10. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.
Gromeier M; Brown MC; Zhang G; Lin X; Chen Y; Wei Z; Beaubier N; Yan H; He Y; Desjardins A; Herndon JE; Varn FS; Verhaak RG; Zhao J; Bolognesi DP; Friedman AH; Friedman HS; McSherry F; Muscat AM; Lipp ES; Nair SK; Khasraw M; Peters KB; Randazzo D; Sampson JH; McLendon RE; Bigner DD; Ashley DM
Nat Commun; 2021 Jan; 12(1):352. PubMed ID: 33441554
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.
Kubelt C; Hattermann K; Sebens S; Mehdorn HM; Held-Feindt J
Int J Oncol; 2015; 46(6):2515-25. PubMed ID: 25845427
[TBL] [Abstract][Full Text] [Related]
13. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.
Nickel GC; Barnholtz-Sloan J; Gould MP; McMahon S; Cohen A; Adams MD; Guda K; Cohen M; Sloan AE; LaFramboise T
PLoS One; 2012; 7(4):e35262. PubMed ID: 22536362
[TBL] [Abstract][Full Text] [Related]
14. Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
Prabhu A; Kesarwani P; Kant S; Graham SF; Chinnaiyan P
Neuro Oncol; 2017 Nov; 19(12):1599-1606. PubMed ID: 28541485
[TBL] [Abstract][Full Text] [Related]
15. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications.
Gobin M; Nazarov PV; Warta R; Timmer M; Reifenberger G; Felsberg J; Vallar L; Chalmers AJ; Herold-Mende CC; Goldbrunner R; Niclou SP; Van Dyck E
Cancer Res; 2019 Mar; 79(6):1226-1238. PubMed ID: 30674534
[TBL] [Abstract][Full Text] [Related]
16. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Tang H; Liu W; Xu Z; Zhao J; Wang W; Yu Z; Wei M
J Cell Mol Med; 2021 Jun; 25(12):5534-5546. PubMed ID: 33960636
[TBL] [Abstract][Full Text] [Related]
17. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
Mahlokozera T; Vellimana AK; Li T; Mao DD; Zohny ZS; Kim DH; Tran DD; Marcus DS; Fouke SJ; Campian JL; Dunn GP; Miller CA; Kim AH
Neuro Oncol; 2018 Mar; 20(4):472-483. PubMed ID: 29244145
[TBL] [Abstract][Full Text] [Related]
18. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
19. Adult classical glioblastoma with a BRAF V600E mutation.
Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H
World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
Riehmer V; Gietzelt J; Beyer U; Hentschel B; Westphal M; Schackert G; Sabel MC; Radlwimmer B; Pietsch T; Reifenberger G; Weller M; Weber RG; Loeffler M;
Genes Chromosomes Cancer; 2014 Jul; 53(7):589-605. PubMed ID: 24706357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
